We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Plans Meetings to Hear Office Updates, Bioequivalence Challenges
FDA Plans Meetings to Hear Office Updates, Bioequivalence Challenges
September 24, 2013
The FDA will hold a series of day-long meetings and workshops over the next few months to hear updates from several of its offices, including the Office of Generic Drugs, and to discuss challenges associated with a number of the agency’s ongoing or upcoming initiatives.